About the Laboratory
Our breast cancer research team discovers biomarkers or signatures that can be translated into clinically-relevant modalities, and elucidate the underlying pathophysiology that predisposes or causes breast cancer.
We are both a wet- and dry-lab equipped for molecular biology and histology, and computational biology.
We collaborate with our BIDMC breast pathologists and oncologists, and epidemiologists at the Nurses' Health Study and Harvard T.H Chan School of Public Health.
Dr. Heng is the PI of the Transgender breast care working group at BIDMC, as well as the Transmasculine and Testosterone Therapy research cohort.